Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy. (Q64932628)
Jump to navigation
Jump to search
scientific article published in December 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy. |
scientific article published in December 1998 |
Statements
Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy. (English)
1 reference
Turgeon N
1 reference
Fishman JA
1 reference
Basgoz N
1 reference
Tolkoff-Rubin NE
1 reference
Doran M
1 reference
Cosimi AB
1 reference
Rubin RH
1 reference
1 December 1998
1 reference
1 reference
66
1 reference
12
1 reference
1780-1786
1 reference
Identifiers
1 reference